Equities

AtriCure Inc

ATRC:NMQ

AtriCure Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)36.63
  • Today's Change-1.57 / -4.11%
  • Shares traded278.00
  • 1 Year change+4.45%
  • Beta1.4065
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

  • Revenue in USD (TTM)447.57m
  • Net income in USD-38.92m
  • Incorporated2000
  • Employees1.20k
  • Location
    AtriCure Inc7555 Innovation WayMASON 45040United StatesUSA
  • Phone+1 (513) 755-4100
  • Fax+1 (513) 755-4567
  • Websitehttps://www.atricure.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Alphatec Holdings Inc572.74m-177.87m1.32bn839.00------2.30-1.27-1.274.080.15460.80891.117.73682,644.80-25.12-30.97-32.00-39.4769.4766.02-31.06-46.221.15-3.660.9596--37.4539.38-23.36--67.92--
STAAR Surgical Co341.22m21.78m1.43bn1.06k66.243.3451.704.190.43810.43816.908.690.67632.033.15323,128.804.326.774.927.9078.7376.896.389.165.38--0.00020.0013.3721.07-46.1833.8551.95--
Adapthealth Corp3.26bn-217.76m1.44bn10.70k--0.94858.730.4409-1.64-1.6424.2311.270.709621.158.45304,912.50-4.57-4.34-5.14-4.8919.0318.28-6.44-6.470.99512.290.5757--7.73---1,169.99------
Inmode Ltd423.75m153.67m1.47bn581.0010.432.169.523.471.851.855.048.920.52391.5810.15729,339.1019.0031.3220.7735.6481.6484.4636.2639.659.91--0.000.008.3237.4922.5454.6513.10--
Myriad Genetics, Inc.823.60m-116.00m1.47bn2.70k--2.01--1.78-1.30-1.309.218.040.73859.916.84305,037.00-10.40---12.43--69.15---14.08--1.73-105.000.0506--11.03---135.09------
Evolent Health Inc2.46bn-104.23m1.68bn4.70k--1.60115.250.6814-0.9129-0.912921.5510.660.953--6.14524,309.40-2.79-9.60-3.58-12.5915.9624.50-2.93-13.66---0.55950.3285--45.2625.65-660.71---6.18--
AtriCure Inc447.57m-38.92m1.79bn1.20k--3.84--3.99-0.8322-0.83229.569.540.73651.638.41372,977.50-6.40-3.72-7.35-4.1074.7974.36-8.70-7.642.59-13.760.1194--20.8414.6434.49--46.56--
Rxsight Inc128.29m-30.69m1.80bn374.00--6.60--14.06-0.8194-0.81943.406.890.52121.996.32343,029.40-12.47---13.62--68.44---23.92--11.71--0.0005--81.77--27.19------
Patterson Companies, Inc.6.53bn168.41m1.83bn7.60k11.341.927.100.28011.831.8371.2210.802.275.8615.35859,640.705.841.1310.151.8121.0320.982.570.51570.67237.910.4474304.751.503.34-10.4218.102.170.00
10X Genomics Inc629.74m-182.55m1.90bn1.26k--2.63--3.01-1.53-1.535.265.970.66772.406.72500,193.00-19.36-25.52-21.99-29.0566.6375.88-28.99-48.534.12--0.00--19.8133.43-53.67--49.15--
Integra Lifesciences Holdings Corp1.56bn-6.54m1.91bn3.95k--1.2614.991.22-0.0881-0.088120.2219.730.4011.595.99396,583.90-0.16773.33-0.20023.6859.2963.67-0.41827.990.72614.050.54280.00-1.030.9219-62.482.19-2.97--
Novocure Ltd577.74m-149.78m1.93bn1.45k--5.34--3.34-1.39-1.395.373.340.48793.598.74397,617.30-12.65-7.74-20.29-8.9576.4277.22-25.93-14.691.44--0.6446---5.3015.47-123.75--32.19--
Tandem Diabetes Care Inc854.35m-126.78m2.04bn2.40k--8.59--2.39-1.94-1.9413.083.620.90042.908.23355,979.60-13.36-10.08-17.47-12.2349.7951.77-14.84-11.592.32--0.5945---6.6832.39-135.33--76.81--
Premier Inc1.28bn147.17m2.21bn2.90k16.621.158.411.731.381.3711.6519.980.3562--2.99439,914.103.837.084.788.9567.2461.2910.7616.05----0.277127.320.76842.03-31.70-11.93-2.76--
Omnicell Inc1.06bn-17.69m2.25bn3.66k--1.8433.882.11-0.3917-0.391723.1726.590.47045.904.06291,563.30-0.78171.73-1.112.2541.4446.69-1.662.920.9529--0.31720.00-11.487.82-460.68--0.235--
Conmed Corp1.29bn131.74m2.31bn4.00k17.682.4811.341.794.234.2341.3830.210.5551.715.58322,029.005.680.89726.621.0255.6554.9510.231.651.065.220.5021139.1619.067.68179.9910.042.890.00
Data as of Nov 12 2024. Currency figures normalised to AtriCure Inc's reporting currency: US Dollar USD

Institutional shareholders

52.09%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20244.50m9.23%
AllianceBernstein LPas of 30 Jun 20244.20m8.64%
BlackRock Fund Advisorsas of 30 Jun 20243.67m7.53%
Champlain Investment Partners LLCas of 30 Jun 20242.67m5.49%
Macquarie Investment Management Business Trustas of 30 Jun 20242.00m4.10%
First Light Asset Management LLCas of 30 Jun 20241.96m4.04%
Hood River Capital Management LLCas of 30 Jun 20241.78m3.65%
Fidelity Management & Research Co. LLCas of 30 Jun 20241.77m3.64%
Wellington Management Co. LLPas of 30 Jun 20241.53m3.15%
SSgA Funds Management, Inc.as of 30 Jun 20241.28m2.63%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.